Cogent Biosciences Inc. stock price

Today's NASDAQ:COGT chart, history & news

Price:
8.32 USD
Change:
+0.09 (1.09%)

Key stats

Price open 8.26
Previous close 8.23
Market cap 161.47M
Volume 314.33K
Day high 8.52
Day low 8.12
Year high 14.44
Year low 0.295
Year to date change -24.82%
P/E ratio N.A
Company Profile
Fundamentals
Insider Information
News

About Cogent Biosciences Inc.

Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases. The most advanced clinical program, PLX9486, is a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. KIT D816V is responsible for driving systemic mastocytosis, a serious disease caused by unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Cogent Biosciences is headquartered in Cambridge, MA.

Company information

Company name
Cogent Biosciences Inc.
Exchange
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Address
N.A

Latest Cogent Biosciences Inc. news